(CHSN) Chanson International - Ratings and Ratios
Bakery, Bread, Pastries, Seasonal, Beverages
Description: CHSN Chanson International
Chanson International Holding is a China-based company that operates a chain of bakeries, offering a diverse range of bakery products, seasonal items, and beverages to individual and corporate customers across China, the Cayman Islands, and the United States. The companys product portfolio includes cakes, bread, sweets, snacks, birthday cakes, cookies, and beverages, sold under brand names such as George Chanson, Patisserie Chanson, and Chanson. In addition to its bakery products, the company provides eat-in services in its stores and sells its products through digital platforms and third-party online food ordering platforms.
From a business perspective, Chanson International Holding has undergone significant changes, having been incorporated in 2019 and rebranded from RON Holding Limited to its current name in December 2020. As a subsidiary of Danton Global Limited, the company is headquartered in Urumqi, China. With a presence in the rapidly growing Chinese bakery market, Chanson is well-positioned to capitalize on the increasing demand for premium bakery products.
Analyzing the available
Based on the available data, a forecast for Chanson International Holdings stock price could be constructed by analyzing the companys growth prospects, industry trends, and technical indicators. Assuming the company continues to expand its bakery chain and digital presence, and considering the growing demand for premium bakery products in China, a potential price target for CHSN could be estimated. If the stock price continues to trend upwards, breaking above its SMA20 and SMA50, it may attract further investor interest, potentially driving the price towards $0.60-$0.80 in the short term. However, the stocks long-term performance will depend on the companys ability to maintain its growth momentum and improve its profitability.
CHSN Stock Overview
| Market Cap in USD | 7m |
| Sub-Industry | Restaurants |
| IPO / Inception | 2023-03-30 |
CHSN Stock Ratings
| Growth Rating | -85.3% |
| Fundamental | 46.0% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -98.9% |
| Analyst Rating | - |
CHSN Dividends
Currently no dividends paidCHSN Growth Ratios
| Growth Correlation 3m | -91.9% |
| Growth Correlation 12m | -89.3% |
| Growth Correlation 5y | -42.6% |
| CAGR 5y | -82.55% |
| CAGR/Max DD 3y | -0.83 |
| CAGR/Mean DD 3y | -0.95 |
| Sharpe Ratio 12m | -0.01 |
| Alpha | 1.00 |
| Beta | 0.001 |
| Volatility | 145.46% |
| Current Volume | 116.2k |
| Average Volume 20d | 232k |
| Stop Loss | 2.5 (-7.7%) |
| Signal | -1.01 |
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-80.0 TTM) > 0 and > 6% of Revenue (6% = 795.1k TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 15.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 32.34% (prev -79.68%; Δ 112.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 1.24m > Net Income -80.0 (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.8m) change vs 12m ago 156.2% (target <= -2.0% for YES) |
| Gross Margin 42.27% (prev 46.44%; Δ -4.18pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.04% (prev 17.61%; Δ 15.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -255.0 (EBITDA TTM -67.0k / Interest Expense TTM 3573 ) >= 6 (WARN >= 3) |
Altman Z'' 0.58
| (A) 0.10 = (Total Current Assets 18.4m - Total Current Liabilities 14.1m) / Total Assets 41.8m |
| (B) 0.01 = Retained Earnings (Balance) 391.3k / Total Assets 41.8m |
| (C) -0.02 = EBIT TTM -911.2k / Avg Total Assets 40.1m |
| (D) 0.03 = Book Value of Equity 700.9k / Total Liabilities 23.4m |
| Total Rating: 0.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.96
| 1. Piotroski 1.50pt = -3.50 |
| 2. FCF Yield 13.39% = 5.0 |
| 3. FCF Margin 8.51% = 2.13 |
| 4. Debt/Equity 0.71 = 2.26 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= -7.41)% = -9.26 |
| 7. RoE -0.00% = -0.00 |
| 8. Rev. Trend 13.02% = 0.98 |
| 9. EPS Trend -32.86% = -1.64 |
What is the price of CHSN shares?
Over the past week, the price has changed by +1.50%, over one month by -17.38%, over three months by -84.39% and over the past year by -98.63%.
Is Chanson International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHSN is around 2.75 USD . This means that CHSN is currently overvalued and has a potential downside of 1.48%.
Is CHSN a buy, sell or hold?
What are the forecasts/targets for the CHSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.9 | 7% |
Last update: 2025-09-15 04:33
CHSN Fundamental Data Overview
CCE Cash And Equivalents = 12.1m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 2.9796
P/S = 0.3863
P/B = 0.1362
Beta = -2.863
Revenue TTM = 13.3m USD
EBIT TTM = -911.2k USD
EBITDA TTM = -67.0k USD
Long Term Debt = 9.21m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 3.83m USD (from shortTermDebt, last quarter)
Debt = 13.0m USD (Calculated: Short Term 3.83m + Long Term 9.21m)
Net Debt = 937.8k USD (from netDebt column, last quarter)
Enterprise Value = 8.42m USD (7.48m + Debt 13.0m - CCE 12.1m)
Interest Coverage Ratio = -255.0 (Ebit TTM -911.2k / Interest Expense TTM 3573 )
FCF Yield = 13.39% (FCF TTM 1.13m / Enterprise Value 8.42m)
FCF Margin = 8.51% (FCF TTM 1.13m / Revenue TTM 13.3m)
Net Margin = -0.00% (Net Income TTM -80.0 / Revenue TTM 13.3m)
Gross Margin = 42.27% ((Revenue TTM 13.3m - Cost of Revenue TTM 7.65m) / Revenue TTM)
Tobins Q-Ratio = 12.02 (Enterprise Value 8.42m / Book Value Of Equity 700.9k)
Interest Expense / Debt = 0.03% (Interest Expense 3573 / Debt 13.0m)
Taxrate = 8.98% (74.6k / 830.9k)
NOPAT = -911.2k (EBIT -911.2k, no tax applied on loss)
Current Ratio = 1.30 (Total Current Assets 18.4m / Total Current Liabilities 14.1m)
Debt / Equity = 0.71 (Debt 13.0m / last Quarter total Stockholder Equity 18.4m)
Debt / EBITDA = -194.6 (Net Debt 937.8k / EBITDA -67.0k)
Debt / EBITDA = -194.6 --> set to None
Debt / FCF = 11.56 (Debt 13.0m / FCF TTM 1.13m)
Total Stockholder Equity = 15.2m (last 4 quarters mean)
RoA = -0.00% (Net Income -80.0, Total Assets 41.8m )
RoE = -0.00% (Net Income TTM -80.0 / Total Stockholder Equity 15.2m)
RoCE = -3.73% (Ebit -911.2k / (Equity 15.2m + L.T.Debt 9.21m))
RoIC = -5.20% (NOPAT -911.2k / Invested Capital 17.5m)
WACC = 2.21% (E(7.48m)/V(20.5m) * Re(6.02%)) + (D(13.0m)/V(20.5m) * Rd(0.03%) * (1-Tc(0.09)))
Shares Correlation 3-Years: 40.00 | Cagr: 5.32%
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈1.13m ; Y1≈740.4k ; Y5≈338.6k
Fair Price DCF = 6.20 (DCF Value 6.66m / Shares Outstanding 1.07m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -32.86 | EPS CAGR: -98.27% | SUE: N/A | # QB: 0
Revenue Correlation: 13.02 | Revenue CAGR: -35.37% | SUE: N/A | # QB: None
Additional Sources for CHSN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle